Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies (Q38258014)

1 September 2017

1 reference

title

Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies (English)

1 reference

1 September 2017

1 reference

Monica Logan

1

1 reference

PubMed ID

25294164

1 September 2017

Shannon M Hawkins

series ordinal

2

1 reference

PubMed ID

25294164

1 September 2017

language of work or name

English

0 references

publication date

1 February 2015

1 reference

1 September 2017

1 reference

1 September 2017

128

1 reference

1 September 2017

153-180

1 reference

1 September 2017

3

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 September 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Minireview: The roles of small RNA pathways in reproductive medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Role for a bidentate ribonuclease in the initiation step of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

microPrimer: the biogenesis and function of microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miRBase: microRNA sequences, targets and gene nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA Cancer Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A-to-I editing challenger or ally to the microRNA process

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miRNA editing--we should have inosine this coming

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Discovery of novel microRNAs in female reproductive tract using next generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Complexity of the microRNA repertoire revealed by next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A mammalian microRNA expression atlas based on small RNA library sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

In-depth characterization of the microRNA transcriptome in a leukemia progression model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The mammalian ovary from genesis to revelation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Structural basis of microRNA length variety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Deep-sequencing of human Argonaute-associated small RNAs provides insight into miRNA sorting and reveals Argonaute association with RNA fragments of diverse origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A comprehensive survey of 3' animal miRNA modification events and a possible role for 3' adenylation in modulating miRNA targeting effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The fate of miRNA* strand through evolutionary analysis: implication for degradation as merely carrier strand or potential regulatory molecule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Cancer-associated somatic DICER1 hotspot mutations cause defective miRNA processing and reverse-strand expression bias to predominantly mature 3p strands through loss of 5p strand cleavage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Interaction-based discovery of functionally important genes in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Homodimeric structure and double-stranded RNA cleavage activity of the C-terminal RNase III domain of human dicer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Dicer1 functions as a haploinsufficient tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Oncogene-dependent control of miRNA biogenesis and metastatic progression in a model of undifferentiated pleomorphic sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Deletion of Dicer in somatic cells of the female reproductive tract causes sterility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Dicer is required for female reproductive tract development and fertility in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Role of Dicer in female fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Dicer, Drosha, and outcomes in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

An international assessment of ovarian cancer incidence and mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Ovarian cancer stem cells: are they real and why are they important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Rethinking ovarian cancer: recommendations for improving outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Trastuzumab in the adjuvant treatment of HER2-positive early breast cancer patients: a meta-analysis of published randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Regulation of specific target genes and biological responses by estrogen receptor subtype agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA expression and identification of putative miRNA targets in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Genetic analysis of cancer-implicated MicroRNA in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA genes and their target 3'-untranslated regions are infrequently somatically mutated in ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Early events in the pathogenesis of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Aberrant microRNA expression likely controls RAS oncogene activation during malignant transformation of human prostate epithelial and stem cells by arsenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Ovarian cancer : making its own rules-again

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

An analysis of human microRNA and disease associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Ovarian surface epithelium as a source of ovarian cancers: unwarranted speculation or evidence-based hypothesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The origin of ovarian cancers--hypotheses and controversies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

High-grade serous ovarian cancer arises from fallopian tube in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Identification of ovarian cancer metastatic miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Identification of a chrXq27.3 microRNA cluster associated with early relapse in advanced stage ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Special commentary: patient safety and the next generation of HPV DNA tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Development and impact of human papillomavirus vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Microarray profile of micro-ribonucleic acid in tumor tissue from cervical squamous cell carcinoma without human papillomavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Patterns of known and novel small RNAs in human cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A microRNA expression signature for cervical cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Altered MicroRNA expression in cervical carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Systematic validation of hypothesis-driven candidate genes for cervical cancer in a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Effects of common polymorphisms rs2910164 in miR-146a and rs3746444 in miR-499 on cancer susceptibility: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Has-miR-146a polymorphism (rs2910164) and cancer risk: a meta-analysis of 19 case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A pri-miR-218 variant and risk of cervical carcinoma in Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Identification and validation of human papillomavirus encoded microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

microRNAs are biomarkers of oncogenic human papillomavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-203 suppresses tumor growth and angiogenesis by targeting VEGFA in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Potential molecular mechanisms for improved prognosis and outcome with neoadjuvant chemotherapy prior to laparoscopical radical hysterectomy for patients with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Comprehensive miRNA profiling of surgically staged endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The expression of the miRNA-200 family in endometrial endometrioid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA signatures differentiate uterine cancer tumor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Expression profile of mammalian microRNAs in endometrioid adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The microRNA-200 family is upregulated in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Aberrant microRNA expression in endometrial carcinoma using formalin-fixed paraffin-embedded (FFPE) tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA miR-302 inhibits the tumorigenicity of endometrial cancer cells by suppression of Cyclin D1 and CDK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Histopathology of genetically defined endometrial precancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Estrogen Regulation of MicroRNA Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Assessing endometrial hyperplasia and carcinoma treated with progestin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Endometrial exosomes/microvesicles in the uterine microenvironment: a new paradigm for embryo-endometrial cross talk at implantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Prognostic significance of miR-194 in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Upregulation of TrkB promotes epithelial-mesenchymal transition and anoikis resistance in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Integrated genomic characterization of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Therapeutic synergy between microRNA and siRNA in ovarian cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Compensatory pathways induced by MEK inhibition are effective drug targets for combination therapy against castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Alternative dosing of dual PI3K and MEK inhibition in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

mTOR signaling and drug development in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Argonaute proteins: key players in RNA silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Many roads to maturity: microRNA biogenesis pathways and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miRNAs: whys and wherefores of miRNA-mediated regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Computational identification of Drosophila microRNA genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Complementary miRNA pairs suggest a regulatory role for miRNA:miRNA duplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Epigenetic alteration and microRNA dysregulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Genomic DNA copy-number alterations of the let-7 family in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Deregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The effects of MicroRNA transfections on global patterns of gene expression in ovarian cancer cells are functionally coordinated.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The upregulation of signal transducer and activator of transcription 5-dependent microRNA-182 and microRNA-96 promotes ovarian cancer cell proliferation by targeting forkhead box O3 upon leptin stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Genetic variation that predicts platinum sensitivity reveals the role of miR-193b* in chemotherapeutic susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a/125b and DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Oncogenic MicroRNA-27a is a target for genistein in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Increased sensitivity to chemotherapy induced by CpG-ODN treatment is mediated by microRNA modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-30c-2* expressed in ovarian cancer cells suppresses growth factor-induced cellular proliferation and downregulates the oncogene BCL9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A combined array-based comparative genomic hybridization and functional library screening approach identifies mir-30d as an oncomir in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin α5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The biphasic expression pattern of miR-200a and E-cadherin in epithelial ovarian cancer and its correlation with clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Chemoresistance in ovarian cancer linked to expression of microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Prognostic significance of serum microRNA-221 expression in human epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A genetic variant in pre-miR-27a is associated with a reduced cervical cancer risk in southern Chinese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

An anti-let-7 sponge decoys and decays endogenous let-7 functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Interferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Up-regulated miR155 reverses the epithelial-mesenchymal transition induced by EGF and increases chemo-sensitivity to cisplatin in human Caski cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-181b promotes cell proliferation and reduces apoptosis by repressing the expression of adenylyl cyclase 9 (AC9) in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-182 plays an onco-miRNA role in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-205 expression promotes cell proliferation and migration of human cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-223 regulates FOXO1 expression and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

The microRNA-302-367 cluster suppresses the proliferation of cervical carcinoma cells through the novel target AKT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-375 is upregulated in acquired paclitaxel resistance in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-590 promotes cervical cancer cell growth and invasion by targeting CHL1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A specific miRNA signature promotes radioresistance of human cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

CpG island hypermethylation-associated silencing of microRNAs promotes human endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-138 suppresses neutrophil gelatinase-associated lipocalin expression and inhibits tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Up-regulation of microRNA-145 promotes differentiation by repressing OCT4 in human endometrial adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Silencing of miR-148a in cancer-associated fibroblasts results in WNT10B-mediated stimulation of tumor cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Bortezomib induces apoptosis of endometrial cancer cells through microRNA-17-5p by targeting p21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endometrial adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Expression of the tumor suppressor miR-206 is associated with cellular proliferative inhibition and impairs invasion in ERα-positive endometrioid adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Prognostic significance of miR-205 in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

MicroRNA and transcription factor mediated regulatory network for ovarian cancer: regulatory network of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Joint Bayesian inference of condition-specific miRNA and transcription factor activities from combined gene and microRNA expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Network analysis of microRNAs and their regulation in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Integrating sequence, expression and interaction data to determine condition-specific miRNA regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Epigenetic analysis of the Notch superfamily in high-grade serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Identifying multi-layer gene regulatory modules from multi-dimensional genomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Discovery of multi-dimensional modules by integrative analysis of cancer genomic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20140087

Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1002/CNCR.21649

Identifiers

DOI

10.1042/CS20140087

1 reference

1 September 2017

1 reference

PubMed ID

25294164